Wang, Y., Pan, S., Tian, J., Wang, J., Yu, Y., Wang, S., . . . Meng, F. (2025). Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma. Cancer Immunology, Immunotherapy, 74(6), . https://doi.org/10.1007/s00262-025-04038-8
Chicago-referens (17:e uppl.)Wang, Yilin, et al. "Cadonilimab, a PD-1/CTLA-4 Bispecific Antibody in Unresectable Hepatocellular Carcinoma." Cancer Immunology, Immunotherapy 74, no. 6 (2025). https://doi.org/10.1007/s00262-025-04038-8.
MLA-referens (9:e uppl.)Wang, Yilin, et al. "Cadonilimab, a PD-1/CTLA-4 Bispecific Antibody in Unresectable Hepatocellular Carcinoma." Cancer Immunology, Immunotherapy, vol. 74, no. 6, 2025, https://doi.org/10.1007/s00262-025-04038-8.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
